KING OF PRUSSIA, PA — Genomind has been awarded a federal contract to support a new Defense Health Agency initiative aimed at improving how medications are prescribed to U.S. active-duty ...

Providence researchers and physicians are harnessing the power of artificial intelligence to find patterns hidden among ...

SickKids is providing the C-GUIDE™ tool evaluation of iHope's genomic testing for the diagnosis, care, and well-being ...

In the fast-changing landscape of the health and wellness sector, businesses require more than generic solutions. They seek platforms that can evolve in accordance with their distinct vision, branding ...

The oncolytic virus therapy landscape has expanded steadily over the past decade, with over 100 companies worldwide pursuing clinical or preclinical programs. A few leaders, such as Candel ...

As a doctor working in genomic research, I know that we lack vital data for Black people and many other groups. Here's how we ...

Over a century after Mendel established the foundations of inheritance, genomics has revealed that most human traits and common diseases arise from the ...

Multiple Myeloma (MM) research is at the forefront of personalized medicine, driven by rapid advancements in laboratory genomics and molecular diagnostics.

ConcertAI, a leading oncology real-world evidence data and AI SaaS technology company, and Foundation Medicine, a global, patient-focused precision medicine company, today announced a collaboration to ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...

Partnership unites Illumina's leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for early detection and prevention. SAN DIEGO and MENLO ...